Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

The emergent outbreak of coronavirus disease 2019 (COVID-19) has caused a global pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are among the leading causes of death in critically ill patients with COVID-19. The elevated inflammatory cytokines suggest that a cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bingwen, Li, Min, Zhou, Zhiguang, Guan, Xuan, Xiang, Yufei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151347/
https://www.ncbi.nlm.nih.gov/pubmed/32291137
http://dx.doi.org/10.1016/j.jaut.2020.102452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151347/
https://www.ncbi.nlm.nih.gov/pubmed/32291137
http://dx.doi.org/10.1016/j.jaut.2020.102452

Ejemplares similares